Lipid Emulsion Infusion and COVID-19 Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

September 20, 2021

Study Completion Date

September 26, 2021

Conditions
Covid19
Interventions
DRUG

SMOFlipid

Intravenous fish-oil-based lipid (SMOF lipid 20%) (Fresenius Kabi, Bad Homburg, Germany) emulsion supplementation to standard enteral nutrition in a dose of 100 ml/day at a rate of 12.5 ml/h over 8 h daily for 5 days.

OTHER

0.9% saline

Receive standard enteral nutrition plus 100 ml/day 0.9% normal saline at a rate 12.5 ml/h over 8 h for 5 days

Trial Locations (1)

Assuit universi

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER